Title |
Chemotherapy-related cognitive dysfunction: current animal studies and future directions
|
---|---|
Published in |
Brain Imaging and Behavior, August 2013
|
DOI | 10.1007/s11682-013-9250-3 |
Pubmed ID | |
Authors |
R. Seigers, S. B. Schagen, O. Van Tellingen, J. Dietrich |
Abstract |
Cognitive impairment is a potential long-term side effect of adjuvant chemotherapy that can have a major impact on the quality of life of cancer survivors. There is a growing number of preclinical studies addressing this issue, thereby extending our knowledge of the mechanisms underlying chemotherapy-induced neurotoxicity. In this review, we will summarize the recent advances and important findings presented in these studies. Emerging challenges, such as the development of neuroprotective strategies, and the role of the blood-brain barrier on cognitive impairment will be described and future directions in this field of investigation will be outlined. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Science communicators (journalists, bloggers, editors) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Unknown | 108 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 20 | 18% |
Student > Master | 16 | 15% |
Researcher | 15 | 14% |
Student > Bachelor | 11 | 10% |
Student > Doctoral Student | 9 | 8% |
Other | 22 | 20% |
Unknown | 16 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Psychology | 21 | 19% |
Medicine and Dentistry | 20 | 18% |
Neuroscience | 15 | 14% |
Agricultural and Biological Sciences | 7 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 6% |
Other | 16 | 15% |
Unknown | 23 | 21% |